Global Bioprocess Containers Market valued at $3 billion in 2021, is expected to witness a significant CAGR of 27% by 2026 - Growing Biologics & Vaccines Market

Bioprocess Containers (BPCs) are ready-to-use single-use flexible container systems for liquid handling applications in biopharmaceutical and biomanufacturing operations.

Multiple Benefits of Ready-To-Use Single-Use Bioprocess Container Systems Fuels Its Global Market Demand

Single-use technology (SUT) products are accepted globally for the manufacturing of vaccines and biologics. Some of the primary benefits which are driving its demand are as follows:

• Operational Benefits and Reduced Risk of Cross-Contamination: Bioprocess container systems reduce the risk of cross-contamination. Moreover, the elimination of cleaning-in-place and sterilization-in-place systems reduce setup, maintenance and validation times, thus enabling more output.
• Ready Integration: Bioprocess container components work well in all the stages in the production of therapeutic biologics and vaccines.
• Reduction in Cost of Goods Sold (COGS): Bioprocess container systems reduce the capital investment and labor costs, which in turn leads to a reduction in COGS.
• Scalability: Bioprocess container systems are well suited for utilization from benchtop to production scale processes.

High Development & Manufacturing Costs of Biologics Coupled with Its Patent Expiry is Likely to Drive the Demand of
Single-Use Bioprocessing Technologies

Biologics currently hold nearly half of the pharmacological market for oncology. By 2023, patents on nearly 20 oncology biologics are expected to expire. Patent expiry of biologics is expected to result in a significant growth in the R&D of biologics and a turn move of biologics from pipeline stage to commercial production.

The development of biologics including cell & gene therapies and therapeutic vaccines demand high sterility and thus biologics are being rapidly manufactured using single-use equipment and consumables.

As the development and manufacturing costs of biologics are very high, many biopharmaceutical manufacturers are incorporating single-use bioprocessing technologies into their development processes.

"Biopharmaceutical manufacturers use a range of bioprocess containers (BPCs) during the production and storage of biopharmaceuticals. The trend of "single-use" or "disposable" BPC technologies in the biopharmaceutical industry enables greater flexibility and better use of production facilities which are increasingly designed for multiple products."-Senior Director, Top Bioprocess Container (BPC) Manufacturer, United States

Competitive Landscape Analysis: Bioprocess Containers Market

The global bioprocess containers market is marked by the presence of established market players such as Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Merck Millipore (Germany), and others.

Get Detailed Insights on Bioprocess Containers Market with a Sample Report PDF @ https://meditechinsights.com/bioprocess-containers-market/

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

This release was published on openPR.